Abstract

Innovative Microfluidic-based Technics For Advanced Therapy Medicinal Product (ATMP) for the Treatment of Type-1 Diabetes

Frederic Bottausci, Senior Engineer, Commissariat à l’Energie Atomique et aux Energies Alternatives (CEA)

As part of the European consortium BIOCAPAN, we present preliminary results of an innovative advance therapy medicinal product for the treatment of type 1 diabetes and some severe cases of type 2 diabetes based on microencapsulation of insulin secreting islets.